1st Berlin Releases Research Update Following Callisto Pharmaceutical's Announcement of Initiation of Phase II Trial in Advanced Carcinoid Cancer Patients
14th Nov 2006, 18:54 GMT
Independent German Based Equity Research Firm Maintains Buy Rating
1st Berlin Releases Research Update Following Callisto Pharmaceutical's Announcement of Initiation of Phase II Trial in Advanced Carcinoid Cancer Patients related news:
- First Berlin Releases Research Update Following Callisto Pharmaceutical's Announcement Of Initiation Of Phase II Trial In Advanced Carcinoid Cancer — Health News from Medical News Today
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer — PR Newswire: All Releases
- CuraGen, TopoTarget initiate ovarian cancer trial — Pharmaceutical Business Review Latest News
- Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers: Phase II Trials Initiated — Health News from Medical News Today
- Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival — Health News from Medical News Today
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
- Reata brain cancer therapy shows strong activity — Pharmaceutical Business Review Latest News
- Human Genome reports positive results on lupus drug — Pharmaceutical Business Review Latest News
- Aeterna prostate cancer drug shows promise — Pharmaceutical Business Review Latest News
- Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers — Health News from Medical News Today
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement